Aquabounty Technologies Inc (AQB) Expected to Announce Quarterly Sales of $120,000.00
Analysts expect Aquabounty Technologies Inc (NASDAQ:AQB) to post sales of $120,000.00 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Aquabounty Technologies’ earnings, with the lowest sales estimate coming in at $20,000.00 and the highest estimate coming in at $220,000.00. The business is scheduled to announce its next earnings report on Thursday, March 14th.
According to Zacks, analysts expect that Aquabounty Technologies will report full year sales of $200,000.00 for the current year, with estimates ranging from $100,000.00 to $300,000.00. For the next financial year, analysts anticipate that the company will post sales of $1.11 million, with estimates ranging from $600,000.00 to $1.62 million. Zacks’ sales averages are an average based on a survey of research analysts that cover Aquabounty Technologies.
Aquabounty Technologies (NASDAQ:AQB) last issued its earnings results on Friday, November 2nd. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by ($0.01). The firm had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.14 million.
Shares of AQB stock traded down $0.18 during trading hours on Tuesday, hitting $2.30. The stock had a trading volume of 61,700 shares, compared to its average volume of 91,714. Aquabounty Technologies has a one year low of $2.25 and a one year high of $9.99. The company has a current ratio of 0.98, a quick ratio of 0.94 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $36.24 million, a price-to-earnings ratio of -2.17 and a beta of -0.68.
An institutional investor recently raised its position in Aquabounty Technologies stock. Morgan Stanley increased its stake in Aquabounty Technologies Inc (NASDAQ:AQB) by 744.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,999 shares of the company’s stock after acquiring an additional 31,738 shares during the period. Morgan Stanley owned approximately 0.24% of Aquabounty Technologies worth $115,000 as of its most recent SEC filing. 53.75% of the stock is owned by hedge funds and other institutional investors.
Aquabounty Technologies Company Profile
AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.